| Serial Number | 79340988 |
| Word Mark | NRAVEL |
| Filing Date | Monday, August 23, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 5, 2023 |
| Registration Number | 7232511 |
| Registration Date | Tuesday, December 5, 2023 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 19, 2023 |
| Certificate of Correction for Registration | In statement Class 42, has been updated in accordance with the F-note dated 03/08/2024. |
| Goods and Services | Pharmaceutical and veterinary preparations, in particular medicines for human beings and animals, for the treatment of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; human and animal sample materials, for medical purposes, namely, tumor tissues and tissue grafts samples, blood, serum, plasma, urine, stools, allograft or xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites being bodily fluids, cerebrospinal fluid, human and animal urine and human and animal stool; test kits of human and animal sample materials, comprising diagnostic reagents for medical purposes, namely, human and animal allograft and xenograft tissue, tissue cuts being biological tissue grafts and biological tissue cultures, blood plasma, blood serum, ascites being bodily fluids, cerebrospinal fluid, human and animal urine and human and animal stool; diagnostic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for medical use; therapeutic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods, for medical use for the treatment of cancer; biological material collections, namely, biological tissue cultures for medical purposes; cancer material collections, namely, biological tissue being resected and biopsy tumor and adjacent non-tumor tissue from the human body including epithelial, connective, muscular, and nervous tissues, blood, serum, plasma, urine, stools for medical purposes; medical sample collections, namely, biological tissue cultures for medical purposes; biological sample collections from the human body, namely, epithelial, connective, muscular, and nervous tissues, blood, serum, plasma, urine, stools for medical purposes; biopsy material collections, namely, biological tissue in the nature of blood, biological tissue grafts and biological tissue cultures for medical purposes; all the afore-mentioned in particular with regard to the field of oncology |
| Pseudo Mark | N RAVEL |
| Goods and Services | Medical analyses in connection with the treatment of individuals including medical analysis of X-rays and blood samples, namely, medical testing for diagnostic and treatment purposes; medical clinic services; pharmaceutical advisory services; medical analysis services using bioinformatics and computational biology, for patient diagnostic and treatment purposes; providing supporting services and advice to hospitals and other medical care centres, namely, collecting and stabilizing of human and animal biospecimens, providing advice related thereto, and the collection of related clinical data for patient diagnostic and treatment purposes; all the afore-mentioned in particular with regard to the field of oncology |
| Goods and Services | Collection of clinical data for medical research and development of therapeutics and diagnostics; collecting genetic, medical, biomedical, biologic, chemical and biochemical data and information, in particular information generated through the use of imaging techniques, the use of liquid biopsy methods, the use of histopathological analysis and procedures, the use of genetic analysis and the use of genomics, proteomics, transcriptomics, metabolomics, lipidomics and/or glycomics studies and analysis for medical research; scientific and technological services, namely, research, design and development of new technology for others in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; industrial analysis and research services in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; design and development of computer hardware and software, in particular computer programs; scientific research for medical purposes, namely, molecular biological, immunological and histological laboratory services, in particular research and development in the field of human medical and veterinary medical diagnostics and therapy; typing of tissue and tissue samples, in particular using molecular biological, immunological, genetic engineering and histological methods for research purposes; preparation of human and animal biospecimen for research purposes; providing information and data relating to medical and veterinary research on human and animal biospecimen, in particular genomic, epigenomic, proteomic, phosphoproteomic, RNA, transcriptomic, lipidomic and metabolomic data; medical laboratory services for medical research purposes, other than for diagnostic or treatment purposes, namely, typing of tissue and tissue samples, in particular using molecular biological, immunological, genetic engineering and histological methods; database design and development; software as a service (SAAS) services, namely, hosting software for use by others for use as a database; installation, maintenance and updating of database software; providing scientific research information and results from an online searchable database; programming of computer software for databases; scientific and laboratory analysis using bioinformatics and computational biology in the field of oncology; all the afore-mentioned in particular with regard to the field of oncology |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 23, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 23, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 23, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Indivumed GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Party Name | Indivumed GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Party Name | Indivumed GmbH |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Party Name | Indivumed GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Event Date | Event Description |
| Thursday, May 19, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, May 23, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 25, 2022 | ASSIGNED TO EXAMINER |
| Friday, May 27, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, May 27, 2022 | NON-FINAL ACTION WRITTEN |
| Saturday, May 28, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, June 22, 2022 | REFUSAL PROCESSED BY MPU |
| Thursday, June 23, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, July 13, 2022 | REFUSAL PROCESSED BY IB |
| Wednesday, December 7, 2022 | CORRECTION CREATED FOR IB |
| Wednesday, December 7, 2022 | CORRECTION CREATED FOR IB |
| Wednesday, December 7, 2022 | CORRECTION SENT TO IB |
| Wednesday, December 7, 2022 | CORRECTION SENT TO IB |
| Wednesday, December 21, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 21, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 21, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 26, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, January 26, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, January 26, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 28, 2023 | REFUSAL PROCESSED BY IB |
| Monday, July 24, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 24, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 25, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 11, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, August 11, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, August 11, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, August 11, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, August 11, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 30, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 30, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 30, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, September 19, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 24, 2023 | NOTIFICATION PROCESSED BY IB |
| Wednesday, October 25, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, October 25, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, October 30, 2023 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Monday, October 30, 2023 | USPTO CORRECTION PROCESSED BY IB |
| Sunday, November 12, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, December 5, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 5, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, March 5, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, March 13, 2024 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Thursday, March 14, 2024 | FINAL DISPOSITION PROCESSED |
| Thursday, March 14, 2024 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
| Thursday, March 14, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, April 8, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, April 23, 2024 | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED |
| Tuesday, May 14, 2024 | USPTO CORRECTION PROCESSED BY IB |